Exploring MMDA. To explore a different substance…

Names:
MMDA · 3-Methoxy-4,5-methylenedioxyamphetamine
IUPAC names:
1-(7-Methoxy-2H-1,3-benzodioxol-5-yl)propan-2-amine
1-(7-Methoxy-1,3-benzodioxol-5-yl)propan-2-amine
ID: 132 · Formula: C11H15NO3 · Molecular weight: 209.242
InChI: InChI=1S/C11H15NO3/c1-7(12)3-8-4-9(13-2)11-10(5-8)14-6-15-11/h4-5,7H,3,6,12H2,1-2H3

Passie, T; Benzenhöfer, U. MDA, MDMA and other mescaline-like substances in the US military’s search for a truth drug (1940s to 1960s). Drug Test. Analysis, 31 Aug 2017, n/a-n/a. 840 kB. http://dx.doi.org/10.1002/dta.2292

Shulgin, AT. Chemistry and structure-activity relationships of the psychotomimetics. In Psychotomimetic Drugs; Efron, DH, Ed., Raven Press, New York, 1970; pp 21–41. 8.6 MB.

Shulgin, AT; Sargent, T; Naranjo, C. The chemistry and psychopharmacology of nutmeg and of several related phenylisopropylamines. In Ethnopharmacologic Search for Psychoactive Drugs; Efron, DH; Holmstedt, B; Kline, NS, Eds., U.S. Department of Health and Human Services, National Institute of Health, U.S. Government Printing Office, Washington, DC, 28 Jan 1967; pp 202–215. 951 kB.

Shulgin, AT; Sargent, T; Naranjo, C. Animal pharmacology and human psychopharmacology of 3-methoxy-4,5-methylenedioxyphenylisopropylamine (MMDA). Pharmacology, 1 Jan 1973, 10 (1), 12–18. 3.0 MB. http://dx.doi.org/10.1159/000136416 Rhodium.

Benzenhõfer, U; Passie, T. Rediscovering MDMA (ecstasy): the role of the American chemist Alexander T. Shulgin. Addiction, 1 Aug 2010, 105 (8), 1355–1361. 794 kB. http://dx.doi.org/10.1111/j.1360-0443.2010.02948.x

Shulgin, AT. Profiles of psychedelic drugs. 3. MMDA. J. Psychedelic Drugs, 1 Jan 1976, 8 (4), 331. 1.5 MB. http://dx.doi.org/10.1080/02791072.1976.10471859

Shulgin, AT; Sargent, T; Naranjo, C. Structure-activity relationships of one-ring psychotomimetics. Nature, 1 Jan 1969, 221, 537–541. 537 kB. http://dx.doi.org/10.1038/221537a0

Shulgin, AT. Possible implication of myristicin as a psychotropic substance. Nature, 1 Jan 1966, 210, 380–384. 707 kB. http://dx.doi.org/10.1038/210380a0

Shulgin, AT. 3-Methoxy-4,5-methylenedioxy amphetamine, a new psychotomimetic agent. Nature, 1 Jan 1964, 201, 1120–1121. 212 kB. http://dx.doi.org/10.1038/2011120a0 Rhodium.

Altun, A; Golcuk, K; Kumru, M; Jalbout, AF. Electron-conformation study for the structure-hallucinogenic activity relationships of phenylalkylamines. Bioorg. Med. Chem., 1 Dec 2003, 11 (24), 3861–3868. 577 kB. http://dx.doi.org/10.1016/S0968-0896(03)00437-1

Thakur, M; Thakur, A; Khadikar, PV. QSAR studies on psychotomimetic phenylalkylamines. Bioorg. Med. Chem., 15 Feb 2004, 12 (4), 825–831. 323 kB. http://dx.doi.org/10.1016/j.bmc.2003.10.027

McKenna, DJ; Guan, AM; Shulgin, AT. 3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential effects on synaptosomal release of 3H-dopamine and 3H-5-hydroxytryptamine. Pharmacol. Biochem. Behav., 1 Jan 1991, 38 (3), 505–12. 783 kB. http://dx.doi.org/10.1016/0091-3057(91)90005-M

White, TJ; Goodman, D; Shulgin, AT; Castagnoli, N; Lee, R; Petrakis, NL. Mutagenic activity of some centrally active aromatic amines in Salmonella typhimurium. Mutat. Res., 1 Jan 1977, 56 (2), 199–202. 256 kB. http://dx.doi.org/10.1016/0027-5107(77)90210-X

Shulgin, AT. Psychotomimetic amphetamines: Methoxy 3,4-dialkoxyamphetamines. Experientia, 1 Jan 1964, 20 (7), 366–367. 240 kB. http://dx.doi.org/10.1007/BF02147960

Shulgin, AT. Psychotomimetic drugs: structure-activity relationships. In Handbook of Psychopharmacology: Stimulants; Iversen, LL; Iversen, SD; Snyder, SH, Eds., Plenum Press, New York, 1978; Vol. 11, pp 243–333. 2.6 MB. http://dx.doi.org/10.1007/978-1-4757-0510-2_6 Rhodium.

Weil, AT. The use of nutmeg as a psychotropic agent. Bull. Narc., United Nations Office on Drugs and Crime, 1 Jan 1966.

MMDMA
LOPHOPHINE
α-Et-Lophophine
DMMDA-2
5-Me-MDA · 5-Methyl-MDA
5F-MDA
MEDA
TMA
MPDA · MTDA
Myristicin
cis-Isomyristicin
Isomyristicin
FLEA
MDMEO
MMDA-2
MMDA-3a
MMDA-3b
MMDA-5
MMDA-4
2,5-DMA-βk · 2,5-Dimethoxycathinone
homo-MDOH
2,4-DMA-βk
N-iPr-DHPEA-βk
MHMC
HMMC
HOBDB
2-HO-N-Me-5-EPEA-βk
2-MDMOH
N-Me-2C-3a
2C-HM
6-MDMOH
β-Me-2C-2
5-MDMOH
N-Me-Lophophine
3,4-Dimethoxycathinone
2,4-Dimethoxycathinone
MMDMA
LOPHOPHINE
α-Et-Lophophine
DMMDA-2
5-Me-MDA · 5-Methyl-MDA
5F-MDA
MEDA
TMA
MPDA · MTDA
Myristicin
cis-Isomyristicin
Isomyristicin
FLEA
MDMEO
MMDA-2
MMDA-3a
MMDA-3b
MMDA-5
MMDA-4
2,5-DMA-βk · 2,5-Dimethoxycathinone
homo-MDOH
2,4-DMA-βk
N-iPr-DHPEA-βk
MHMC
HMMC
HOBDB
2-HO-N-Me-5-EPEA-βk
2-MDMOH
N-Me-2C-3a
2C-HM
6-MDMOH
β-Me-2C-2
5-MDMOH
N-Me-Lophophine
3,4-Dimethoxycathinone
2,4-Dimethoxycathinone
19 November 2017 · Creative Commons BY-NC-SA ·